logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/06/2026
Jim Reid of Deutsche Bank pointed out: Not only are we oscillating between whether the US and Iran will reach an agreement, but the market is also switching back and forth between the AI frenzy of 1999 and the tech stock crash of 2000. Now, all that is lacking is a volatile US CPI data today to continue this pattern.
Latest
2 m ago
ST Cloud Network: Partial removal of risk warnings, stock abbreviation changed to "ST Cloud Network"
2 m ago
In May, US CPI data showed inflation soaring to a three-year high, but the moderate rise in core prices eased Wall Street's concerns about rate hikes. Today's CPI data and tomorrow's PPI index are expected to influence the Federal Reserve's policy stance, which will be announced at the Federal Reserve meeting hosted by Powell for the first time in a week. According to CME Federal Reserve observations, before the release of CPI inflation data, the market had estimated a 70% probability of the Federal Reserve raising rates by the end of 2026. However, the market believes that it is unlikely for the Federal Reserve to raise rates at next week's meeting, with only a 13% probability of a rate hike at the July meeting. The focus in the short term is whether the Federal Reserve will clearly shift from a loose preference stance to a neutral or tight preference stance at the upcoming meeting. This week's CPI and PPI inflation data, as well as progress in US-Iran negotiations, may affect the balance between neutrality and tightening.
3 m ago
Trump Media & Technology Group: No plans to proceed with the spinoff of assets such as Truth Social at this time.
3 m ago
Taimei Medical Technology (02576.HK) spent 444,900 Hong Kong dollars to repurchase 100,000 shares on June 10th.
3 m ago
Tebao Biotechnology (688278.SH): The clinical trial application for ACT201 injection has received an acceptance notice.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.